Skip to main content

Invitrogen's License of Harvard Chemistry Topped Most-Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Dec. 14.
 
1. Invitrogen Licenses Harvard's Click Chemistry Technology for Cell-Based Assays (from Dec. 10)
 
2. Gene Logic Shareholders OK Sale of Genomic Business, Name Change (from Dec. 11)
 
3. NIH to Grant $43M in FY 2009 Under Shared Instruments Program (from Dec. 10)
 
4. FDA Relabels Carbamazepine to Recommend Genetic Test for Risk of Skin Reactions (from Dec. 12)
 
5. Harvard Bio Gets $5 Per Share Buyout Offer from Investor (from Dec. 14)
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.